Apolipoprotein(a) phenotypes as genetic markers of coronary atherosclerosis severity

International Journal of Cardiology

Volumn 64, Issue 3, 1998, Pages 277-284

  Gazzaruso, Carmine ^a   Geroldi, Diego ^a   Garzaniti, Adriana ^a   Falcone, Colomba ^b   Fratino, Pietro ^c   Finardi, Giorgio ^a   Buscaglia, Paola ^a  

^a Dept Int Med and Med Therapeut   (Italy)

^b FONDAZIONE IRCCS POLICLINICO SAN MATTEO   (Italy)

^c UNIVERSITY OF PAVIA   (Italy)

Author keywords

Apolipoprotein(a) polymorphism; Atherosclerosis; Coronary disease; Lipoprotein(a)

Indexed keywords

APOLIPOPROTEIN A;

ADULT; AGED; ANGIOCARDIOGRAPHY; ARTICLE; CORONARY ARTERY ATHEROSCLEROSIS; CORONARY ARTERY OBSTRUCTION; DISEASE SEVERITY; FEMALE; GENETIC MARKER; HUMAN; MAJOR CLINICAL STUDY; MALE; MOLECULAR WEIGHT; PHENOTYPE; PRIORITY JOURNAL; STATISTICAL ANALYSIS;

ANALYSIS OF VARIANCE; APOLIPOPROTEINS A; CHI-SQUARE DISTRIBUTION; CORONARY ANGIOGRAPHY; CORONARY ARTERIOSCLEROSIS; ELECTROPHORESIS, AGAR GEL; FEMALE; GENETIC MARKERS; HUMANS; IMMUNOBLOTTING; LIPIDS; MALE; MIDDLE AGED; PHENOTYPE; POLYMORPHISM, GENETIC; RISK FACTORS; SENSITIVITY AND SPECIFICITY; STATISTICS, NONPARAMETRIC;

EID: 0032524502     PISSN: 01675273     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0167-5273(98)00050-3     Document Type: Article

References (38)

1. Rhoads J.J., Dahlen G.H., Berg K., Morton N.E., Dannenberg A.L. Lp(a) lipoprotein as a risk factor for myocardial infarction. J Am Med Assoc. 256:1986;2540-2544.
2. Dalhen G.H., Guyton J.R., Attar M., Farmer J.A., Kautz J.A., Gotto A.M. Association of levels of lipoprotein(a), plasma lipids, and other lipoproteins with coronary artery disease documented by angiography. Circulation. 74:1986;758-765.
3. Hoefler G., Harnoncourt F., Paschke E., Mirti W., Pfeiffer K.H., Kostner G.M. Lipoprotein Lp(a). A risk factor for myocardial infarction. Arteriosclerosis. 8:1988;398-401.
4. Rosengren A., Wilhelmsen L., Eriksson E., Risberg B., Wedel H. Lipoprotein(a) and coronary heart disease: a prospective case-control study in a general population sample of middle aged men. Br Med J. 301:1990;1248-1251.
5. Scanu A.M., Fless G.M. Lipoprotein (a). Heterogeneity and biological relevance. J Clin Invest. 85:1990;1709-1715.
6. Ilyas Kamboh M., Ferrel R.E., Kottke B.A. Expressed hypervariable polymorphism of apolipoprotein(a). Am J Hum Genet. 49:1991;1063-1074.
7. Geroldi D., Bellotti V., Buscaglia P.et al. Characterization of apo(a) polymorphism by a modified immunoblotting technique in an Italian population sample. Clin Chim Acta. 221:1993;159-169.
8. Lackner C., Cohen J.C., Hobbs H.H. Molecular definition of the extreme size polymorphism in apolipoprotein(a). Hum Mol Genet. 2:1993;933-940.
9. Marcovina S.M., Zhang Z.H., Gaur V.P., Albers J.J. Identification of 34 apolipoprotein(a) isoforms: differential expression of apolipoprotein(a) alleles between American blacks and whites. Biochem Biophys Res Commun. 191:1993;1192-1196.
10. Boerwinkle E., Leffert C.C., Lin C., Lackner G., Chiesa G., Hobbs H.H. Apolipoprotein(a) gene accounts for greater than 90% of the variation in plasma lipoprotein(a) concentration. J Clin Invest. 90:1992;52-60.
11. Boerwinkle E. Genetics of plasma lipoprotein(a) concentrations. Curr Opin Lipid. 3:1992;128-136.
12. Sandholzer C., Saha N., Kark T.D.et al. Apo(a) isoforms predict risk for Coronary Heart Disease. Arterioscler Thromb. 12:1992;1214-1226.
13. Abe A., Noma A., Lee Y.J., Yamaguchi H. Studies on apolipoprotein(a) phenotypes. Part 2. Phenotype frequencies and Lp(a) concentration in different phenotypes in patients with angiographically defined coronary artery diseases. Atherosclerosis. 96:1992;9-15.
14. Seed M., Hoppichler F., Reaveley D.et al. Relation of serum Lipoprotein(a) concentration and apolipoprotein(a) phenotype to coronary heart disease in patients with familial hypercholesterolemia. New Engl J Med. 322:1990;1494-1499.
15. Kraft H.G., Lingenhel A., Kochl S.et al. Apolipoprotein(a) Kringle IV repeat number predicts risk for coronary heart disease. Arterioscler Thromb Vasc Biol. 16:1996;713-719.
16. Gazzaruso C., Buscaglia P., Garzaniti A.et al. Association of lipoprotein(a) levels and apolipoprotein(a) phenotypes with coronary heart disease in patients with essential hypertension. J Hypertens. 15:1997;227-235.
17. Hearn J.A., DeMaio S.J., Roubin G.S., Hammarstrom M., Sgoutas D. Predictive value of Lipoprotein (a) and other serum lipoproteins in the angiographic diagnosis of coronary artery disease. Am J Cardiol. 66:1990;1176-1180.
18. Korhonen T., Savolainen M.J., Koistinen M.J.et al. Association of lipoprotein cholesterol and triglycerides with the severity of coronary artery disease in men and women. Atherosclerosis. 127:1996;213-220.
19. Averna M.R., Barbagallo M.C., Ocello S.et al. Lp(a) levels in patients undergoing aorta-coronary by-pass surgery. Eur Heart J. 13:1992;1405-1409.
20. Wang X.L., Tam C., McCredie R.M., Wilcken D.E.L. Determinants of severity of coronary artery disease in Australian men and women. Circulation. 89:1994;1974-1981.
21. Budde T., Fechtrup C., Bosenberg E.et al. Plasma Lp(a) levels correlate with number, severity and length-extension of coronary lesions in male patients undergoing coronary arteriography for clinically suspected coronary atherosclerosis. Arterioscler Thromb. 14:1994;1730-1736.
22. Terres W., Tatsis E., Pfalzer B., Beil F.U., Beisigel U., Hamm C.W. Rapid angiographic progression of coronary artery disease in patients with elevated lipoprotein(a). Circulation. 91:1995;248-250.
23. National Diabetes Data Group: classification and diagnosis of diabetes mellitus and other categories of glucose intolerance. Diabetes 1979;28:1039-57.
24. Guidelines for the management of mild hypertension: memorandum from a WHO/ISH meeting. ISH Hypertension News Special Edition, June 1993;3-16.
25. Friedewald W.T., Levy R.I., Fredrikson D.S. Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without ultracentrifuge. Clin Chem. 18:1972;499-502.
26. Li K.M., Wilcken D.E.L., Dudman N.P.B. Effect of serum Lipoprotein(a) on estimation of low density lipoprotein cholesterol by the Friedewald formula. Clin Chem. 40:1994;571-573.
27. Sandholzer C., Boerwinkle E., Saha N., Tong M.C., Utermann G. Apolipoprotein(a) phenotypes, Lp(a) concentration and plasma lipid levels in relation to coronary heart disease in a Chinese population: evidence for the role of the apo(a) gene in coronary heart disease. J Clin Invest. 89:1992;1040-1046.
28. Falcone C., De Servi S., Poma E.et al. Clinical significance of exercise-induced silent myocardial ischaemia in patients with coronary artery disease. J Am Coll Cardiol. 9:1987;295-299.
29. Nwasokwa O.N., Weiss M., Gladstone C., Dodenheimer M.M. Higher prevalence and greater severity of coronary disease: in short versus tall men referred for coronary arteriography. Am Heart J. 133:1997;147-152.
30. Gensini GG. Coronary arteriography. Mount Kisco, N.Y., Futura Publishing Co., 1975;271-74.
31. Brandt P.W.T., Partridge J.B., Wattie W.J. Coronary arteriography; method of presentation of the arteriogram report and scoring system. Clin Radiol. 28:1977;361-365.
32. Gazzaruso C., Buscaglia P., Garzaniti A.et al. Lp(a) plasma concentrations, apo(a) polymorphism and family history of coronary heart disease in patients with essential hypertension. J Cardiovasc Risk. 3:1996;191-197.
33. Buscaglia P, Gazzaruso C, Garzaniti A, Bonetti G, Fratino P, Geroldi D. Lipoprotein(a) polymorphism and insulin treatment in type 2 diabetic patients. Diabetes Care 1995;18:1202-03 (Letter).
34. Buscaglia P., Gazzaruso C., Garzaniti A.et al. Lipoprotein(a) and proliferative diabetic retinopathy in type II diabetes mellitus: a role for isoforms with low molecular weight. Diab Nutr Metab. 9:1996;129-137.
35. Gazzaruso C., Bonetti G., Garzaniti A.et al. Increased plasma concentrations of Lipoprotein(a) for every phenotype of apolipoprotein(a) in patients with chronic renal failure treated by hemodialysis. Nutr Metab Cardiovasc Dis. 6:1996;203-210.
36. Marcovina S.M., Albers J.J., Wijsman E., Zhang Z.H., Chapman N.H., Kennedy H. Differences in Lp(a) concentrations and apo(a) polymorphs between Black and White Americans. J Lipid Res. 37:1996;2569-2585.
37. Liu A.C., Lawn R.M. Vascular interaction of lipoprotein(a). Curr Opin Lipid. 5:1994;269-273.
38. Kang C., Durlach V., Soulat T., Fournier C., Angles-Cano F. Lipoprotein(a) isoforms display differences in affinity for plasminogen-like binding to human mononuclear cells. Arterioscler Thromb Vasc Biol. 17:1997;2036-2043.